DOCSLIB.ORG

Childhood Diarrhea

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Childhood Diarrhea CLINIC CONSULT Childhood Diarrhea PRELIMS.indd 1 18-12-2013 14:38:15 PRELIMS.indd 2 18-12-2013 14:38:15 CLINIC CONSULT Childhood Diarrhea Authors Ajay Kalra MD DCH MNAMS FIAP Erstwhile Professor S.N. Medical College Agra 282 002, Uttar Pradesh, India Vipin M Vashishtha MD FIAP Director & Consultant Pediatrician Mangla Hospital & Research Center Bijnor 246 701, Uttar Pradesh, India JAYPEE BROTHERS MEDICAL PUBLISHERS (P) LTD. New Delhi • London • Philadelphia • Panama PRELIMS.indd 3 18-12-2013 14:38:15 Jaypee Brothers Medical Publishers (P) Ltd Headquarters Jaypee Brothers Medical Publishers (P) Ltd 4838/24, Ansari Road, Daryaganj New Delhi 110 002, India Phone: +91-11-43574357 Fax: +91-11-43574314 Email: [email protected] Overseas Offices J.P. Medical Ltd Jaypee-Highlights Medical Publishers Inc 83 Victoria Street, London City of Knowledge, Bld. 237, Clayton SW1H 0HW (UK) Panama City, Panama Phone: +44-2031708910 Phone: +1 507-301-0496 Fax: +02-03-0086180 Fax: +1 507-301-0499 Email: [email protected] Email: [email protected] Jaypee Medical Inc Jaypee Brothers Medical Publishers (P) Ltd The Bourse 17/1-B Babar Road, Block-B, Shaymali 111 South Independence Mall East Mohammadpur, Dhaka-1207 Suite 835, Philadelphia, PA 19106, USA Bangladesh Phone: +1 267-519-9789 Mobile: +08801912003485 Email: [email protected] Email: [email protected] Jaypee Brothers Medical Publishers (P) Ltd Bhotahity, Kathmandu, Nepal Phone: +977-9741283608 Email: [email protected] Website: www.jaypeebrothers.com Website: www.jaypeedigital.com © 2014, Jaypee Brothers Medical Publishers The views and opinions expressed in this book are solely those of the original contributor(s)/author(s) and do not necessarily represent those of editor(s) of the book. All rights reserved. No part of this publication may be reproduced, stored or transmitted in any form or by any means, electronic, mechanical, photocopying, recording or otherwise, without the prior permission in writing of the publishers. All brand names and product names used in this book are trade names, service marks, trademarks or registered trademarks of their respective owners. The publisher is not associated with any product or vendor mentioned in this book. Medical knowledge and practice change constantly. This book is designed to provide accurate, authoritative information about the subject matter in question. However, readers are advised to check the most current information available on procedures included and check information from the manufacturer of each product to be administered, to verify the recommended dose, formula, method and duration of administration, adverse effects and contraindications. It is the responsibility of the practitioner to take all appropriate safety precautions. Neither the publisher nor the author(s)/editor(s) assume any liability for any injury and/or damage to persons or property arising from or related to use of material in this book. This book is sold on the understanding that the publisher is not engaged in providing professional medical services. If such advice or services are required, the services of a competent medical professional should be sought. Every effort has been made where necessary to contact holders of copyright to obtain permission to reproduce copyright material. If any have been inadvertently overlooked, the publisher will be pleased to make the necessary arrangements at the first opportunity. Inquiries for bulk sales may be solicited at: [email protected] Clinic Consult: Childhood Diarrhea First Edition: 2014 ISBN 978-93-5152-122-8 Printed at PRELIMS.indd 4 18-12-2013 14:38:16 Preface Diarrhea remains the most common problem of children in developing countries. Yet, it is the one most unjudiciously treated. This underscores the need to keep oneself updated on the subject and follow rationale mode of management. We hope that this Clinic Consult will help practitioners to be able to do so. Ajay Kalra Vipin M Vashishtha PRELIMS.indd 5 18-12-2013 14:38:16 PRELIMS.indd 6 18-12-2013 14:38:16 Acknowledgements We have consulted various resource literature to write this book. We are grateful to all those who are mentioned in the bibliography. We are also grateful to the publishers for the wonderful job done. PRELIMS.indd 7 18-12-2013 14:38:16 PRELIMS.indd 8 18-12-2013 14:38:16 Contents Preface v Acknowledgements vii Chapter 1 Diarrhea in Children 1 Chapter 2 Causes and Mechanisms of Diarrhea 5 Chapter 3 Pathogenesis of Diarrhea 10 Chapter 4 Clinical Diagnosis of Diarrhea 14 Chapter 5 Physical Examination 19 Chapter 6 Laboratory Investigations 25 Chapter 7 Management of Acute Diarrhea 28 Chapter 8 Drug Therapy in Diarrhea 42 PRELIMS.indd 9 18-12-2013 14:38:16 Clinic Consult: Childhood Diarrhea Chapter 9 Dietary Management 54 Chapter 10 Persistent/Protracted/Recurrent/Chronic Diarrhea 57 Chapter 11 Celiac Disease 68 Chapter 12 Lactose Intolerance 70 Chapter 13 Cow’s Milk Protein Intolerance 74 Chapter 14 Vaccines Against Diarrheal Diseases 76 Bibliography 81 Normal lactose digestion Lactose intolerance x PRELIMS.indd 10 18-12-2013 14:38:16 CHAPTER 1 Diarrhea in Children INTRODUCTION Diarrhea is a leading cause of morbidity and mortality in developing countries. Each year in developing countries, roughly 4 billion episodes of acute diarrhea take place. In India, a child suffers, on an average, of 10–15 episodes of diarrhea in the first 5 years of life. Of these, 3–6 episodes (average 4.2) may occur in the very first year of life, especially in the urban slums and rural areas. It is responsible for nearly 2 million deaths of children below 5 years age every year in the developing world. The surface area of intestinal mucosa of a child from where the diarrheal fluids are secreted is fairly large. Therefore, a child may lose almost as much water and electrolytes from the body during the episode of diarrhea as an adult. Loss of 1 liter of fluid from the body of a child weighing 7 kg may be more dangerous compared with a similar depletion from an adult of 70 kg weight. Out of all cases of diarrhea, nearly 2–3% would have a significant disturbance in the electrolyte balance and acid base status of the body and this may prove fatal, if fluids and electrolytes are not replaced immediately. Diarrhea has been shown to have significant impact on nutrition. Even a brief episode of diarrhea leads to the loss of 1–2% of body ch-01.indd 1 18-12-2013 14:31:00 Clinic Consult: Childhood Diarrhea weight per day. Infants and young children in developing countries are sick for nearly 30 days per year because of diarrhea. Therefore, such creeping deficit may accumulate to become a major nutritional hazard. If diarrhea becomes unusually prolonged, or is recurrent, the child further becomes severely malnourished. Moreover, the appetite is impaired, and food is often withheld from the child by the mother due to the belief that starvation may provide rest to the bowel and thus promote early recovery. Further, atrophy of the intestinal epithelium in cases of malnutrition causes malabsorption and accentuates malnutrition. A vicious cycle of diarrhea–malnutrition–diarrhea sets in, contributing to a large majority of early childhood deaths either directly or indirectly. DEFINITION When a person has watery motions, it is called diarrhea. Diarrhea does not always mean many motions. Even one watery motion can be diarrhea. This is also regardless of its cause, its color, or any illness associated with it. Diarrhea can be very dangerous, especially in very small or weak children. This is because diarrhea leads to dehydration, which may cause death. That is why one must start treating a child for diarrhea as soon as the child passes even one watery motion. Young infants usually pass about 5 g of stool per kg of body weight per day, while diarrhea results in stool output greater than 10 g/kg/day. WHAT IS NOT DIARRHEA? • Frequent semiformed or watery greenish yellow stools in the initial days of life (transitional stools). Due to some weight 2 ch-01.indd 2 18-12-2013 14:31:00 Diarrhea in Children loss, they are often thought of as diarrhea. It is self-limiting and requires no treatment • Formed or pasty stools frequently passed in exclusively breastfed babies • Passing a stool immediately after feed by infants 3–6 months of age: It is due to exaggerated gastrocolic pattern, quite normal at this stage and requires no treatment CLASSIFICATION OF DIARRHEA Acute diarrhea: It is passage of several watery and loose stools in a day which generally terminate within 7 days (only rarely 14–28 days). Persistent diarrhea: World Health Organization (WHO) defines this as a diarrheal illness, which begins acutely and lasts for 14 days or more. More than 60% episodes occur in infants less than 6 months and 90% before 1 year of age. Chronic diarrhea: It is diarrhea of more insidious onset with stools, which are less watery in nature and semisolid. Their frequency may be four to five times per day. It is seen more in children above 3 years of age. Dysentery: It is presence of visible blood in stool. It is usually accompanied by pus and abdominal cramps and fever. Shigella is the most common cause requiring treatment with antibiotics. Acute infective diarrhea may be both “noninflammatory” or “inflammatory”. Noninflammatory diarrhea is due to enterotoxin produced by bacteria, destruction of villus (surface cells) by viruses, or adherence by parasites. Diarrhea may be inflammatory due to bacteria that invade intestine directly or produce cytotoxins. 3 ch-01.indd 3 18-12-2013 14:31:00 Clinic Consult: Childhood Diarrhea KEY MESSAGES Diarrhea is a leading cause of morbidity and mortality in children in the developing world It can lead to dehydration and associated acid–base disturbances which, if not recognized and treated, can prove fatal Recurrent/prolonged diarrhea can cause malnutrition and failure to thrive Many normal physiological stooling patterns are confused with diarrhea and treated unnecessarily.
Load more

Recommended publications
  • Palliative Care Case of the Month
    PALLIATIVE CARE CASE OF THE MONTH “Treating Non-Infectious Diarrhea” by Robert Arnold, MD Volume 19, No. 98 August, 2019 Case 1: Mr. Jones is a 58-year-old man with short gut Three drugs are used because of their ability to slow down the syndrome. Palliative Care was consulted for goals of care, gut, allowing for more time for absorption of intestinal fluids a however quickly it became clear uncontrolled diarrhea was a decrease of diarrhea. The most well-know is loperamide, a larger priority. He said having to change the bag every few hours synthetic opiate which has minimal absorption. The dosing is 4 completely interfered with his living a normal life. He said, “I’d mg after one’s first bowel movement and then 2 mg after every rather die than have all of this diarrhea.” unformed stool, up to 16 mg (in palliative care patients there is some data for use up to 54 mg).9, 10 Loperamide should be Case 2: A 62-year-old woman with non-small cell lung cancer continued for 12 hours after diarrhea is stopped. Adverse effects is receiving immunotherapy. She has done quite well but is include mostly constipation, abdominal cramps, nausea and distressed by her diarrhea. She tried Lomotil and Imodium but rarely CNS effects like fatigue or dizziness. Cases of torsades de neither worked. When seeing her palliative care doctor, she said, pointes and death have been reported with higher than “It isn’t worth treating my cancer if I can’t live a normal life.” 9 recommended doses.
    [Show full text]
  • Anti-Diarrheal Activity and Brine Shrimp Lethality Bioassay of Methanolic Extract of Cordyline Fruticosa (L.) A
    Naher et al. Clinical Phytoscience (2019) 5:15 https://doi.org/10.1186/s40816-019-0109-z ORIGINAL CONTRIBUTION Open Access Anti-diarrheal activity and brine shrimp lethality bioassay of methanolic extract of Cordyline fruticosa (L.) A. Chev. leaves Sharmin Naher1*, Md. Abdullah Aziz1, Mst. Irin Akter2, S. M. Mushiur Rahman1, Sadiur Rahman Sajon1 and Kishor Mazumder1,3 Abstract Background: Cordyline fruticosa (L.) A. Chev. (Asparagaceae) is a plant which is traditionally used for the treatment of cough, bloody cough, diarrhea, dysentery, high fever, difficulties in urine, bloody urine, small pox, madness, skin eruptions, joint pains, rheumatic bone pains, sore throat, neck pain, bleeding hemorrhoids and inflammation in the digestive tract. Therefore, the present work aims to investigate the antidiarrheal and cytotoxic activities of methanolic extract of Cordyline fruticosa leaves in mice and brine shrimp, respectively. Methods: The effects of the methanol extract of Cordyline fruticosa leaves (MCFL) on castor oil-induced diarrhea, magnesium sulphate induced diarrhea and charcoal meal test in mice were investigated. In addition, brine shrimp lethality bioassay method was used to evaluate cytotoxic activity of MCFL. Results: In castor oil induced diarrheal test, MCFL at the dose of 200, 400 and 800 mg/kg body weight significantly (∗P< 0.05, versus control) and dose-dependently reduced the frequency of diarrhea. The frequency of magnesium sulphate-induced diarrhea was significantly reduced by MCFL at the dose of with 800 mg/kg. In the charcoal meal test, the extract at the dose of 400 and 800 mg/kg body weight significantly (∗P< 0.05) reduced the distance travelled by charcoal along the intestinal tract when compare with control.
    [Show full text]
  • Chronic Diarrhea
    Chronic Diarrhea Barbara McElhanon, MD Subra Kugathasan, MD Emory University School of Medicine 2013 Resident Education Series Reviewed by Edward Hoffenberg, MD of the Professional Education Committee Case • A 15 year old boy with PMH of obesity, anxiety disorder & ADHD presents with 3 months of non-bloody loose stool 5-15 times/day and diffuse abdominal pain that is episodically severe Case - History • Wellbutrin was stopped prior to the onset of her symptoms and her Psychiatrist was weaning Cymbalta • After stopping Cymbalta, she went to Costa Rica for a month long medical mission trip • Started having symptoms of abdominal pain and diarrhea upon return from her trip. • Ingestion of local Georgia creek water, but after her symptoms had started • Subjective fever x 4 days Case - Lab work by PCP • At onset of illness: – + occult blood in stool – + stool calprotectin (a measure of inflammation in the colon) – Negative stool WBC – Negative stool culture – Negative C. difficile – Negative ova & parasite study – Negative giardia antigen – Normal CBC with diff, Complete metabolic panel, CRP, ESR Case - History • Non-bloody diarrhea and abdominal pain continues • No relation to food • No fevers • No weight loss • Normal appetite • No night time occurrences • No other findings on ROS • No sick contacts Case – Work-up prior to visit Labs Imaging and Procedures • MRI enterography (MRI of the • Fecal occult blood, stool abdomen/pelvis with special cuts calprotectin, stool WBC, stool to evaluate the small bowel) culture, stool O&P, stool giardia
    [Show full text]
  • A Pediatrician's Guide to Constipation
    5/8/2018 Pediatric Upsies, Downsies and Oopsies – Diarrhea and Constipation GLENN DUH, M.D. PEDIATRIC GASTROENTEROLOGY KP DOWNEY (TRI-CENTRAL) I have nothing to disclose Objectives Identify the pertinent history information regarding the symptoms of diarrhea, constipation and rectal bleeding. Identify the “red flags“ associated with symptoms of constipation, and diarrhea and rectal bleeding. Describe indicate the workup/treatment/ management of diarrhea, constipation and rectal bleeding. 1 5/8/2018 First things first…what do you mean by “diarrhea”? Stools too soft or loose? Watery stools? Too much coming out? Undigested food in the stools? Soiling accidents with creamy peanut buttery poop in the underwear? Pooping too many times a day? Waking up at night to defecate? Do not assume that we all use the word the same way! First things first…what do you mean by “constipation”? Stools too hard? Bleeding? No poop for a week? Sits on toilet all day and nothing comes out? Stomachaches? KUB showing colon overstuffed with stuff? Do not assume that we all use the word the same way! It’s kind of gross to talk or think about this… 2 5/8/2018 Yummy… Diarrhea NOW THAT WE’VE LOOSENED THINGS UP A BIT…. What is diarrhea? Definition with numbers 3 or more loose stools a day > 10 mL/kg or > 200 grams of stools per day (not sure how one figures this one in the office) Longer than 14 days – chronic diarrhea The “eyeball” test If it looks like a duck, quacks like a duck, waddles like a duck… It doesn’t look like something else 3 5/8/2018 Acute vs.
    [Show full text]
  • Pharmacy and Poisons (Third and Fourth Schedule Amendment) Order 2017
    Q UO N T FA R U T A F E BERMUDA PHARMACY AND POISONS (THIRD AND FOURTH SCHEDULE AMENDMENT) ORDER 2017 BR 111 / 2017 The Minister responsible for health, in exercise of the power conferred by section 48A(1) of the Pharmacy and Poisons Act 1979, makes the following Order: Citation 1 This Order may be cited as the Pharmacy and Poisons (Third and Fourth Schedule Amendment) Order 2017. Repeals and replaces the Third and Fourth Schedule of the Pharmacy and Poisons Act 1979 2 The Third and Fourth Schedules to the Pharmacy and Poisons Act 1979 are repealed and replaced with— “THIRD SCHEDULE (Sections 25(6); 27(1))) DRUGS OBTAINABLE ONLY ON PRESCRIPTION EXCEPT WHERE SPECIFIED IN THE FOURTH SCHEDULE (PART I AND PART II) Note: The following annotations used in this Schedule have the following meanings: md (maximum dose) i.e. the maximum quantity of the substance contained in the amount of a medicinal product which is recommended to be taken or administered at any one time. 1 PHARMACY AND POISONS (THIRD AND FOURTH SCHEDULE AMENDMENT) ORDER 2017 mdd (maximum daily dose) i.e. the maximum quantity of the substance that is contained in the amount of a medicinal product which is recommended to be taken or administered in any period of 24 hours. mg milligram ms (maximum strength) i.e. either or, if so specified, both of the following: (a) the maximum quantity of the substance by weight or volume that is contained in the dosage unit of a medicinal product; or (b) the maximum percentage of the substance contained in a medicinal product calculated in terms of w/w, w/v, v/w, or v/v, as appropriate.
    [Show full text]
  • Western Judicial Circuit Felony Drug Court
    Western Judicial Circuit Felony Drug Court (Athens-Clarke and Oconee Counties) PARTICIPANT HANDBOOK This handbook belongs to: 325 E. Washington Street, Suite 210 Athens, Georgia 30601 (706) 208-7078 (706) 613-3179 (fax) Table of Contents Welcome 3 Overview 4-5 Confidentiality 5 Treatment 5 Program Phases 6-10 Commencement 11 Program Rules 12-14 Program Fees 15 The Drug Court Team 15 Staffings 15 Court Appearances 16 Incentives 17 Sanctions and Treatment Responses 17 Termination 18 Drug/Chemical Testing 19 Prohibited Drugs/Permitted Medications 20-27 Travel/Leave Requests 27 Compliance & Home Visits/Job Checks, Searches 28 Search Requirements 28 Commencement Ceremony 29 Conclusion 29 Important Phone Numbers 30 Community Resources 31 Attachment I: Random Drug Screen Policy Attachment II: Urine Abstinence Testing/Incidental Alcohol Exposure Contract (original signed copy on file with Felony Drug Court) Attachment III: Emergency On-call Telephone Policy Attachment IV: Felony Drug Court Contract 2 Welcome to the Western Judicial Circuit Felony Drug Court! This Handbook was designed to answer your questions and provide specific information about what you must do in order to successfully complete the requirements of the Western Judicial Circuit Felony Drug Court Program. As a participant, you are expected to follow the instructions found in this Handbook, as well as the instructions of the Felony Drug Court Judge, Staff, and Treatment Provider. You will also be expected to comply with the treatment plan developed for you by your Treatment Provider. This handbook is not exhaustive and there is no possible way to make it complete and detailed to answer every question or situation that arises.
    [Show full text]
  • Sydney Medical Program Smp2014
    1! SYDNEY MEDICAL PROGRAM SMP2014 LEARNING TOPICS Stage 2 BLOCK 9: Gastroenterology and Nutrition Copyright © 2014 Sydney Medical Program, University of Sydney Compiled by P. Romo and S. Hewson for SUMS 2! CONTENTS • 9.01 – A persistent pain // Peptic ulcer 3 1. Upper gastrointestinal structures 4 2. Upper gastrointestinal motility 5 3. Vomiting 6 4. Gastric secretion 7 5. Causes of upper gastrointestinal bleeding 10 6. Complications of non-steroidal anti-inflammatory drugs 11 7. Early treatment of peptic ulcer 13 8. Medical evaluation in the aged 15 • 9.02 – I’m not a hundred per cent // Coeliac disease 16 1. Function of exocrine pancreas 17 2. Digestion 19 3. Nutrient absorption and transport 20 4. Nutritional approaches to GI disease 21 5. Vitamin and trace metal absorption 24 6. Mechanisms of diarrhoea 25 7. Mucosal immunity 26 8. Spectrum of coeliac disease 27 • 9.03 – Small and sickly // Failure to thrive in infancy 28 1. Normal nutrition in the first 12 months 29 2. Protein-energy malnutrition 31 3. Lactose intolerance 33 4. Understanding failure to thrive 34 5. Causes of diarrhoea 36 6. Management of acute diarrhoea 38 7. Infectious diarrhoea 41 8. Large bowel function 43 • 9.04 – My eyes look yellow // Gallstones 44 1. Bile secretion 45 2. Composition and formation of gallstones 46 3. Mechanisms of abdominal pain 48 4. Psychosocial issues in care of the older person 50 5. Therapeutic options in biliary disease 52 6. Antibiotic treatment in abdominal sepsis 54 • 9.05 – My pain is getting worse // Liver disease/Hep B 56 1.
    [Show full text]
  • (Promax-C) on Castor Oil-Induced Diarrhea in Mice
    World Journal of Advanced Research and Reviews, 2020, 07(03), 194–203 World Journal of Advanced Research and Reviews e-ISSN: 2581-9615, Cross Ref DOI: 10.30574/wjarr Journal homepage: https://www.wjarr.com (RESEARCH ARTICLE) Effects of hydroethanolic extract of Cameroonian propolis (Promax-c) on castor oil- induced diarrhea in mice Michel Archange Fokam Tagne 1, *, Paul Aimé Noubissi 2, Keya Jeremie Teddine Tchoblaouna 1, Gaëtan Olivier Fankem 3, Yaouke Rékabi 1, Hypolyte Akaou 1 and Fernand-Nestor Tchuenguem Fohouo 1, 1 Department of Biological Sciences, Faculty of Science, University of Ngaoundere, Cameroon. 2 Department of Zoology and Animal Physiology, Faculty of Science, University of Buea, Cameroon. 3 Animal Physiology Laboratory, Faculty of Science, University of Yaoundé I, Cameroon. Publication history: Received on 03 September 2020; revised on 14 September 2020; accepted on 17 September 2020 Article DOI: https://doi.org/10.30574/wjarr.2020.7.3.0336 Abstract The aim of our work was to evaluate the effect of hydroethanolic extract of Cameroonian propolis (Promax-c) on castor oil-induced diarrhea in mice. Diarrhea was induced in mice by oral administration 0.5 mL of castor oil in all mice. To determine the effective doses, each mouse received, 30 minutes after the administration of castor oil, one of the single oral doses of Promax-c: 0, 37.5, 75, 150, and 300 mg/kg bw. The mass and frequency of stool were measured and recorded per hour for five hours. The effect of Promax-c on the intestinal motility was evaluated by measuring the distance traveled by the charcoal meal in thirty minutes.
    [Show full text]
  • Section B Changed Classes/Guidelines Final
    EPHMRA ANATOMICAL CLASSIFICATION GUIDELINES 2019 Section B Changed Classes/Guidelines Final Version Date of issue: 24th December 2018 1 A3 FUNCTIONAL GASTRO-INTESTINAL DISORDER DRUGS R2003 A3A PLAIN ANTISPASMODICS AND ANTICHOLINERGICS R1993 Includes all plain synthetic and natural antispasmodics and anticholinergics. A3B Out of use; can be reused. A3C ANTISPASMODIC/ATARACTIC COMBINATIONS This group includes combinations with tranquillisers, meprobamate and/or barbiturates except when they are indicated for disorders of the autonomic nervous system and neurasthenia, in which case they are classified in N5B4. A3D ANTISPASMODIC/ANALGESIC COMBINATIONS R1997 This group includes combinations with analgesics. Products also containing either tranquillisers or barbiturates and analgesics to be also classified in this group. Antispasmodics indicated exclusively for dysmenorrhoea are classified in G2X1. A3E ANTISPASMODICS COMBINED WITH OTHER PRODUCTS r2011 Includes all other combinations not specified in A3C, A3D and A3F. Combinations of antispasmodics and antacids are classified in A2A3; antispasmodics with antiulcerants are classified in A2B9. Combinations of antispasmodics with antiflatulents are classified here. A3F GASTROPROKINETICS r2013 This group includes products used for dyspepsia and gastro-oesophageal reflux. Compounds included are: alizapride, bromopride, cisapride, clebopride, cinitapride, domperidone, levosulpiride, metoclopramide, trimebutine. Prucalopride is classified in A6A9. Combinations of gastroprokinetics with other substances
    [Show full text]
  • MSIR (Morphine) Medical Facts from Drugs.Com 04/07/2015
    MSIR (morphine) medical facts from Drugs.com 04/07/2015 Browse all medications A B C D E F G H I J K L M N O P Q R S T U V W X Y Z Advanced Search Phonetic Search Drugs A-Z Pill Identifier Interactions Checker News Health Professionals Q & A Mednotes Apps Home → Conditions → Pain → MSIR Print Share Sign In or Register MSIR Related Information Availability Pregnancy Category Generic Name: morphine (MOR feen) Prescription only Risk cannot be ruled out Brand Name: AVINza, Kadian, MS Contin CSA Schedule WADA Class High potential for abuse Anti-Doping Classification Overview Side Effects Dosage Interactions More Reviews Average User Rating Reduce Nerve Pain Now Don't Let Neuropathy Symptoms Slow You Down. Get A Free Trial 1 User Review 9.0 Rate it! Now! Manufacturer What is MSIR (morphine)? Purdue Pharma LP Morphine is an opioid pain medication. An opioid is sometimes called a narcotic. Drug Class Morphine is used to treat moderate to severe Narcotic analgesics pain. Short-acting morphine is taken as needed for pain. Related Drugs The extended-release form of this medicine is Chronic Pain for around-the-clock treatment of pain. This tramadol form of morphine is not for use on an as- oxycodone needed basis for pain. Cymbalta Percocet Morphine is not for treating short-term pain just fentanyl after surgery unless you were already taking morphine morphine before the surgery. duloxetine methadone Morphine may also be used for purposes not Dilaudid listed in this medication guide. OxyContin Ultram More... Pain What is the most important information I should know about tramadol MSIR (morphine)? oxycodone naproxen You should not take this medicine if you have severe asthma or breathing problems, a blockage in acetaminophen your stomach or intestines, or a bowel obstruction called paralytic ileus.
    [Show full text]
  • Diarrhea & Malabsorption
    ھذه اﻟﻣﺣﺎﺿرة ھﻲ ﺗﻛرﯾم ﻟﻛل ﻣن ﯾﻌﻣل وﻻ ﯾﻛرّم،ﻟﻛل ﻣن ﯾﻌﻣل ﺑﺎﻟﺧﻔﺎء،ﻟﻛل اﯾﺎدي ﺗدﻓﻌﻧﺎ ﻣن ظﮭورﻧﺎ ﻻ ﻧرى وﺟوه اﺻﺣﺎﺑﮭﺎ Please note: This work is based on male slides except few points will appear pink Diarrhea & Malabsorption Content Explanation Notes Important ❤❤❤❤❤❤❤❤❤❤❤❤❤❤❤❤❤❤❤❤ Objectives and there answers from Dr slides ❤❤❤❤❤❤❤❤❤❤❤❤❤❤❤❤❤❤❤❤ LONG LIVE ABOOD LONG LIVE ABOOD ❤❤❤❤❤❤❤❤❤❤❤❤❤❤❤❤❤❤❤❤ Understand the physiology of fluid in small intestine ❤❤❤❤❤❤❤❤❤❤❤❤❤❤❤❤❤❤❤❤ ● 1.5 liter food LONG LIVE ABOOD ● 7 liters secretions and reabsorbed in small intestine LONG LIVE ABOOD ● 1.4 reabsorbed in large intestine ❤❤❤❤❤❤❤❤❤❤❤❤❤❤❤❤❤❤❤❤ ❤❤❤❤❤❤❤❤❤❤❤❤❤❤❤❤❤❤❤❤ Describe the pathophysiology and causes of various types of diarrhea LONG LIVE ABOOD ● Secretory: Normal stool osmotic gap {bacterial toxin ( E. coli , cholera) LONG LIVE ABOOD Endocrine tumours} ❤❤❤❤❤❤❤❤❤❤❤❤❤❤❤❤❤❤❤❤ ● osmotic: osmotic gap is high , {Malabsorption, osmotic laxatives} ❤❤❤❤❤❤❤❤❤❤❤❤❤❤❤❤❤❤❤❤ ● Exudative: blood and pus in the stool, { inflammatory bowel diseases, LONG LIVE ABOOD and invasive infections} LONG LIVE ABOOD ● Motility-related: {Irritable bowel syndrome (IBS)} ❤❤❤❤❤❤❤❤❤❤❤❤❤❤❤❤❤❤❤❤ ❤❤❤❤❤❤❤❤❤❤❤❤❤❤❤❤❤❤❤❤ LONG LIVE ABOOD Define acute diarrhea and enumerate its common causes LONG LIVE ABOOD ● Less than 2 weeks ❤❤❤❤❤❤❤❤❤❤❤❤❤❤❤❤❤❤❤❤ ● infections (viruses, bacteria, helminths, and protozoa). Food poisoning ❤❤❤❤❤❤❤❤❤❤❤❤❤❤❤❤❤❤❤❤ LONG LIVE ABOOD LONG LIVE ABOOD ❤❤❤❤❤❤❤❤❤❤❤❤❤❤❤❤❤❤❤❤ Define chronic diarrhea and enumerate its common causes ❤❤❤❤❤❤❤❤❤❤❤❤❤❤❤❤❤❤❤❤ ● More than one month LONG LIVE
    [Show full text]
  • Smecta®) in the Symptomatic Treatment of Acute Diarrhoea in Adults
    IPSEN GROUP F-FR-00250-105 CONFIDENTIAL PROTOCOL: FINAL (WITH AMENDMENT NO. 4): 07 JANUARY 2019 PAGE 1/89 PROTOCOL TITLE: EFFICACY OF DIOSMECTITE (SMECTA®) IN THE SYMPTOMATIC TREATMENT OF ACUTE DIARRHOEA IN ADULTS. A MULTICENTRE, RANDOMISED, DOUBLE BLIND, PLACEBO-CONTROLLED, PARALLEL GROUPS STUDY STUDY PROTOCOL STUDY number: F-FR-00250-105 (Diosmectite- BN 00250) EudraCT number: n° 2015-001138-10 Final Version (with Amendment No. 4): 07 January 2019 Sponsor’s Medically Responsible Person: Study Sponsor: PPD Ipsen Pharma SAS PPD 65 quai Georges Gorse Ipsen Pharma SAS 92100 Boulogne-Billancourt, France 65 quai Georges Gorse Tel: PPD 92100 Boulogne-Billancourt, France Fax: PPD Tel: PPD Fax: PPD Monitoring Office: and/or CRO Co-ordinating Investigator: PPD PPD PPD Délégation à la Recherche Ipsen Pharma SAS Centre Hospitalier Régional Universitaire 65 quai Georges Gorse de Lille 92100 Boulogne-Billancourt, France 2, avenue Oscar Lambret, Tel: PPD 59037 Lille, France Cedex Fax: PPD Tel: PPD Fax: PPD Pharmacovigilance/Emergency Contact: PPD Ipsen Innovation, ZI de Courtaboeuf - 5 avenue du Canada - 91940 Les Ulis - France Tel: PPD Tel: PPD – PPD For SAEs reporting: Fax: PPD Email: PPD Persons supplied with this information must understand that it is strictly confidential. Information contained herein cannot be disclosed, submitted for publication or used for any purpose other than that contemplated herein without the sponsor’s prior written authorisation. IPSEN GROUP F-FR-00250-105 CONFIDENTIAL PROTOCOL: FINAL (WITH AMENDMENT NO. 4): 07 JANUARY 2019 PAGE 2/89 INVESTIGATOR’S AGREEMENT Investigator Agreement and Signature: I have read and agree to Protocol F-FR-00250-105 entitled Efficacy of the diosmectite (Smecta®) in the symptomatic treatment of acute diarrhoea in adults.
    [Show full text]